Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19.

Knooihuizen, Sally A I; Aday, Ariel; Lee, William M

Knooihuizen, Sally A I; Aday, Ariel; Lee, William M.

Knooihuizen SAI; Division of Digestive and Liver Diseases, UT Southwestern Medical Center at Dallas, Dallas, TX.
Aday A; Parkland Health and Hospital System, Dallas, TX.
Lee WM; Division of Digestive and Liver Diseases, UT Southwestern Medical Center at Dallas, Dallas, TX.

Hepatology ; 74(1): 519-521, 2021 07.

Article in English | MEDLINE | ID: covidwho-995947

Subject(s)

Anesthetics, Dissociative/adverse effects; COVID-19/complications; Cholangitis, Sclerosing/chemically induced; Ketamine/adverse effects; Biliary Tract/diagnostic imaging; Biliary Tract/pathology; Cholangitis, Sclerosing/diagnostic imaging; Cholangitis, Sclerosing/etiology; Cholangitis, Sclerosing/pathology; Conscious Sedation/adverse effects; Female; Humans; Magnetic Resonance Imaging; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cholangitis, Sclerosing / COVID-19 / Ketamine / Anesthetics, Dissociative Type of study: Case report Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Journal: Hepatology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google